These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37414155)

  • 1. Under the umbrella of depression and Alzheimer's disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
    Fonseca C; Ettcheto M; Bicker J; Fernandes MJ; Falcão A; Camins A; Fortuna A
    Ageing Res Rev; 2023 Sep; 90():101998. PubMed ID: 37414155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β-evoked neurotoxicity and changes in cell morphology in PC12 cells.
    Marsh DT; Sugiyama A; Imai Y; Kato R; Smid SD
    Basic Clin Pharmacol Toxicol; 2024 Mar; 134(3):293-309. PubMed ID: 37697481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review.
    Cooray R; Gupta V; Suphioglu C
    Mol Neurobiol; 2020 Nov; 57(11):4878-4890. PubMed ID: 32813239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
    Kazim SF; Iqbal K
    Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Cannabis-Based Medicine on Alzheimer's Disease by Focusing on the Amyloid β-Modifications: A Systematic Study.
    Farkhondeh T; Khan H; Aschner M; Samini F; Pourbagher-Shahri AM; Aramjoo H; Roshanravan B; Hoyte C; Mehrpour O; Samarghandian S
    CNS Neurol Disord Drug Targets; 2020; 19(5):334-343. PubMed ID: 32640965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice.
    Watt G; Shang K; Zieba J; Olaya J; Li H; Garner B; Karl T
    J Alzheimers Dis; 2020; 74(3):937-950. PubMed ID: 32116258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of the endocannabinoid system for Alzheimer's disease.
    Karl T; Cheng D; Garner B; Arnold JC
    Expert Opin Ther Targets; 2012 Apr; 16(4):407-20. PubMed ID: 22448595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease.
    Ruiz-Pérez G; Ruiz de Martín Esteban S; Marqués S; Aparicio N; Grande MT; Benito-Cuesta I; Martínez-Relimpio AM; Arnanz MA; Tolón RM; Posada-Ayala M; Cravatt BF; Esteban JA; Romero J; Palenzuela R
    J Neuroinflammation; 2021 Sep; 18(1):223. PubMed ID: 34587978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.
    Cheng X; Wu J; Geng M; Xiong J
    Neurobiol Aging; 2014 Jun; 35(6):1217-32. PubMed ID: 24368087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic dysfunction in Alzheimer's disease: From the role of amyloid β-peptide to the α-secretase ADAM10.
    Musardo S; Marcello E
    Eur J Pharmacol; 2017 Dec; 817():30-37. PubMed ID: 28625569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy.
    Abate G; Uberti D; Tambaro S
    Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34204237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease.
    Coles M; Steiner-Lim GZ; Karl T
    Front Neurosci; 2022; 16():962922. PubMed ID: 36117622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer's Disease.
    Rathod SS; Agrawal YO
    Curr Drug Res Rev; 2024; 16(2):94-110. PubMed ID: 37132109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
    Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
    J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of corticosterone and amyloid-beta on proteins essential for synaptic function: implications for depression and Alzheimer's disease.
    Wuwongse S; Cheng SS; Wong GT; Hung CH; Zhang NQ; Ho YS; Law AC; Chang RC
    Biochim Biophys Acta; 2013 Dec; 1832(12):2245-56. PubMed ID: 23928361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease.
    Defelice FG; Ferreira ST
    An Acad Bras Cienc; 2002 Jun; 74(2):265-84. PubMed ID: 12098753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer's Disease.
    Penke B; Szűcs M; Bogár F
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.